NIAID STATEMENT NIH modifies ‘VOICE’ HIV prevention study in Women Oral tenofovir discontinued in clinical trial   A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective. An independent … [Read more...]